Stroke in patients with diabetes mellitus
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The article's objective is to review the key advances in the scientific literature related to the association of stroke with diabetes mellitus and to summarize the current approaches to stroke prevention in diabetic patients. The key findings from the literature regarding stroke incidence in patients with diabetes, specific and nonspecific risk factors of stroke in the diabetic population, such as arterial hypertension, dyslipidemia, hyperglycemia, diabetes duration, diabetic complications, insulin resistance/hyperinsulinemia, course and outcome of stroke in subjects with diabetes and/or hyperglycemia, and the peculiarities of type, site and size of stroke in diabetic patients are discussed. The results of recent clinical trials aimed at correcting hyperglycemia, hypertension, and dyslipidemia, to prevent stroke in people with diabetes, are reviewed. The medical database Medline along with original articles from peer‐reviewed journals were used for analysis. There is convincing evidence suggesting that diabetes mellitus represents a strong independent risk factor of stroke. The contribution of hyperglycemia to increased stroke risk is not proven. Data suggest an association of the full cluster of the insulin resistance syndrome and stroke. Diabetes is a risk factor mainly for ischemic stroke, while its association with hemorrhagic stroke remains controversial. Hyperglycemia is common in stroke patients, but it is not known whether it independently influences the course and outcome of stroke or merely reflects stroke severity and location. Aggressive control of arterial hypertension and dyslipidemia allows to decrease the risk of stroke in diabetic patients substantially, while the importance of glucose control for stroke prevention remains unproven. Copyright © 2004 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 1×
“[266] have shown in the Steno 2 study that intensive multifactorial intervention aimed at correction of hyperglycemia, hypertension, dyslipidemia, microalbuminuria along with aspirin resulted in a reduction of cardiovascular morbidity including nonfatal stroke (20 vs 3 cases in conventionally and intensively treated p…”
BackgroundDiabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824 · cited 2×
“95) for diabetic and nondiabetic patients combined [181].”
BackgroundChiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623 · cited 1×
“4 years resulted in a reduction of cerebrovascular events in the diabetic cohort by 62% and by 23% in people without diabetes [255].”
BackgroundLindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank
Grau, A. J., Weimar, C., Buggle, F., Heinrich, A., Goertler, M., Neumaier, S., Glahn, J., Brandt, T., Hacke, W., & Diener, H.-C. (2001) · Stroke · doi:10.1161/hs1101.098524 · Cited by 998
Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986
Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682
Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study
Vermeer, S. E., den Heijer, T., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2003) · Stroke · doi:10.1161/01.str.0000052631.98405.15 · Cited by 680 · cited 1×
“However, recently, in a further analysis of this study, it was noted that diabetes was associated with new silent brain infarcts in those participants without prevalent infarcts [124].”
ResultBody mass index and the risk of stroke in men
Kurth, T., Gaziano, J. M., Berger, K., Kase, C. S., Rexrode, K. M., Cook, N. R., Buring, J. E., & Manson, J. E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2557 · Cited by 524 · cited 1×
“However, recently in the Physicians’ Health Study, obesity was found to be a risk factor either for stroke or its major subtypes (ischemic or hemorrhagic) independent of diabetes or other risk factors [87].”
BackgroundPrevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study
Vermeer, S. E., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2002) · Stroke · doi:10.1161/hs0102.101629 · Cited by 430 · cited 1×
“[123], in the large population-based Rotterdam Scan Study, did not find any significant association between diabetes and an increased risk of silent cerebral infarcts, while there was an association between diabetes and increased risk of symptomatic infarcts (odds ratio: 0.”
BackgroundPhysical activity and risk for cardiovascular events in diabetic women
Hu, F. B., Stampfer, M. J., Solomon, C., Liu, S., Colditz, G. A., Speizer, F. E., Willett, W. C., & Manson, J. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00009 · Cited by 424
Kothari (2002) · doi:10.1161/01.str.0000020091.07144.c7 · Cited by 420
Keech, A., Colquhoun, D., Best, J., Kirby, A., Simes, R. J., Hunt, D., Hague, W., Beller, E., Arulchelvam, M., Baker, J., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2713 · Cited by 313 · cited 1×
“In the sub-analysis of the LIPID trial, which enrolled 1077 patients with diabetes and 940 with impaired fasting glucose, it was shown that treatment with pravastatin led to a 39% decrease of the stroke incidence in diabetic patients and 42% decrease in those with an impaired fasting glucose [256].”
MethodSacco, R. L., Benson, R. T., Kargman, D. E., Boden-Albala, B., Tuck, C., Lin, I.-F., Cheng, J. F., Paik, M. C., Shea, S., & Berglund, L. (2001) · JAMA · doi:10.1001/jama.285.21.2729 · Cited by 311
Hillen, T., Coshall, C., Tilling, K., Rudd, A. G., McGovern, R., & Wolfe, C. D. A. (2003) · Stroke · doi:10.1161/01.str.0000072985.24967.7f · Cited by 298
Diabetes-related morbidity and mortality in a national sample of U.S. elders
Bertoni, A. G., Krop, J. S., Anderson, G. F., & Brancati, F. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.471 · Cited by 230 · cited 1×
“2 per 1000 person-years, which was higher than the incidence of all other diabetes-related complications but ischemic heart disease [5].”
BackgroundNiskanen, L., Hedner, T., Hansson, L., Lanke, J., Niklason, A., & for the CAPPP study group (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2091 · Cited by 219
Colagiuri, S., Cull, C. A., Holman, R. R., & For the UKPDS Group (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1410 · Cited by 183 · cited 1×
“However, the observational analysis of the UKPDS did not add conclusive evidence to the importance of hyperglycemia as a risk factor of cerebrovascular disorders in people with diabetes [50].”
BackgroundStroke registry in Malmö, Sweden.
Jerntorp, P., & Berglund, G. (1992) · Stroke · doi:10.1161/01.str.23.3.357 · Cited by 181
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., & Horwitz, R. I. (2003) · Neurology · doi:10.1212/01.wnl.0000063318.66140.a3 · Cited by 126
Arauz, A., Murillo, L., Cantú, C., Barinagarrementeria, F., & Higuera, J. (2003) · Stroke · doi:10.1161/01.str.0000090351.41662.91 · Cited by 112
Central Nervous System Findings in a Tenth Decade Autopsy Population
Peress, N. S., Kane, W. C., & Aronson, S. M. (1973) · Progress in Brain Research · doi:10.1016/s0079-6123(08)60707-4 · Cited by 84 · cited 1×
“Earlier autopsy studies showed a relatively high prevalence of infratentorial (brainstem and cerebellar) infarctions and 3 to 4 times higher prevalence of lesions in the areas of the pons and diencephalon in people with diabetes [112,217,218].”
BackgroundHsia, J., Bittner, V., Tripputi, M., & Howard, B. V. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00227-8 · Cited by 43
Cited by
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade, W. T. (2008) · Physical Therapy · doi:10.2522/ptj.20080008 · Cited by 1,084
Raji, C. A., Ho, A. J., Parikshak, N. N., Becker, J. T., Lopez, O. L., Kuller, L. H., Hua, X., Leow, A. D., Toga, A. W., & Thompson, P. M. (2010) · Human Brain Mapping · doi:10.1002/hbm.20870 · Cited by 686
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Akpoveso, O.-O. P., Ubah, E. E., & Obasanmi, G. (2023) · Antioxidants · doi:10.3390/antiox12010123 · Cited by 90
“There are two main forms of stroke that may feature in diabetes, ischemic and hemorrhagic stroke, with both having the potential of significantly increasing morbidity and mortality amongst diabetics [65]; and in the clinic, stroke is manifested as asymptomatic carotid artery occlusion or cerebral small vessel disease…”
Background
Metadata
- Authors
- Mankovsky, B. N., & Ziegler, D.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2004-07
- Volume
- 20
- Issue
- 4
- Pages
- 268-287
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2022742281
- Cited by
- 122
- References
- 38
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.